251 related articles for article (PubMed ID: 1912589)
1. T-cell depletion of HLA-identical transplants in leukemia.
Marmont AM; Horowitz MM; Gale RP; Sobocinski K; Ash RC; van Bekkum DW; Champlin RE; Dicke KA; Goldman JM; Good RA
Blood; 1991 Oct; 78(8):2120-30. PubMed ID: 1912589
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Ringdén O; Horowitz MM; Sondel P; Gale RP; Biggs JC; Champlin RE; Deeg HJ; Dicke K; Masaoka T; Powles RL
Blood; 1993 Feb; 81(4):1094-101. PubMed ID: 8427991
[TBL] [Abstract][Full Text] [Related]
3. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Champlin RE; Passweg JR; Zhang MJ; Rowlings PA; Pelz CJ; Atkinson KA; Barrett AJ; Cahn JY; Drobyski WR; Gale RP; Goldman JM; Gratwohl A; Gordon-Smith EC; Henslee-Downey PJ; Herzig RH; Klein JP; Marmont AM; O'Reilly RJ; Ringdén O; Slavin S; Sobocinski KA; Speck B; Weiner RS; Horowitz MM
Blood; 2000 Jun; 95(12):3996-4003. PubMed ID: 10845940
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation.
Schattenberg A; De Witte T; Preijers F; Raemaekers J; Muus P; Van der Lely N; Boezeman J; Wessels J; Van Dijk B; Hoogenhout J
Blood; 1990 Mar; 75(6):1356-63. PubMed ID: 2310832
[TBL] [Abstract][Full Text] [Related]
6. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
[TBL] [Abstract][Full Text] [Related]
7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
8. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
9. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Hale G; Zhang MJ; Bunjes D; Prentice HG; Spence D; Horowitz MM; Barrett AJ; Waldmann H
Blood; 1998 Dec; 92(12):4581-90. PubMed ID: 9845524
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-leukemia reactions after bone marrow transplantation.
Horowitz MM; Gale RP; Sondel PM; Goldman JM; Kersey J; Kolb HJ; Rimm AA; Ringdén O; Rozman C; Speck B
Blood; 1990 Feb; 75(3):555-62. PubMed ID: 2297567
[TBL] [Abstract][Full Text] [Related]
11. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Soiffer RJ; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman RL; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
Blood; 1997 Apr; 89(8):3039-47. PubMed ID: 9108425
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
Ash RC; Horowitz MM; Gale RP; van Bekkum DW; Casper JT; Gordon-Smith EC; Henslee PJ; Kolb HJ; Lowenberg B; Masaoka T
Bone Marrow Transplant; 1991 Jun; 7(6):443-52. PubMed ID: 1873591
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
15. High incidence of early leukemic relapse in patients given cyclosporin and T cell depleted HLA-identical sibling marrow transplants for acute leukemia in first remission.
Atkinson K; Biggs J; Dodds A; Concannon A; Downs K; Ashby M; McKenzie IF
Aust N Z J Med; 1988 Jun; 18(4):587-93. PubMed ID: 3058104
[TBL] [Abstract][Full Text] [Related]
16. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
[TBL] [Abstract][Full Text] [Related]
17. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
[TBL] [Abstract][Full Text] [Related]
18. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Drobyski WR; Hessner MJ; Klein JP; Kabler-Babbitt C; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 1999 Jul; 94(2):434-41. PubMed ID: 10397710
[TBL] [Abstract][Full Text] [Related]
19. Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation.
Cahn JY; Deconinck E; Tiberghien P; Brion A; Racadot E; Deschaseaux M; Angonin R; Voillat L; Vuillier J; Fontan J; Morel P; Cordonnier JM; Comparot S; Woronoff-Lemsi MC; Hervé P
Hematol Cell Ther; 1999 Apr; 41(2):31-7. PubMed ID: 10344550
[TBL] [Abstract][Full Text] [Related]
20. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.
Drobyski WR; Ash RC; Casper JT; McAuliffe T; Horowitz MM; Lawton C; Keever C; Baxter-Lowe LA; Camitta B; Garbrecht F
Blood; 1994 Apr; 83(7):1980-7. PubMed ID: 8142664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
